Literature DB >> 22182918

Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34.

K Shedden, Y Li, P Ouillette, S N Malek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22182918      PMCID: PMC3634572          DOI: 10.1038/leu.2011.361

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

Review 1.  Chronic lymphocytic leukemia.

Authors:  Nicholas Chiorazzi; Kanti R Rai; Manlio Ferrarini
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

2.  Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.

Authors:  Peter Ouillette; Roxane Collins; Sajid Shakhan; Jinghui Li; Edward Peres; Lisa Kujawski; Moshe Talpaz; Mark Kaminski; Cheng Li; Kerby Shedden; Sami N Malek
Journal:  Blood       Date:  2011-07-27       Impact factor: 22.113

3.  Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia.

Authors:  X Zhang; M Reis; R Khoriaty; Y Li; P Ouillette; J Samayoa; H Carter; R Karchin; M Li; L A Diaz; V E Velculescu; N Papadopoulos; K W Kinzler; B Vogelstein; S N Malek
Journal:  Leukemia       Date:  2011-06-24       Impact factor: 11.528

4.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

5.  Systematic genomic screen for tyrosine kinase mutations in CLL.

Authors:  J R Brown; R L Levine; C Thompson; G Basile; D G Gilliland; A S Freedman
Journal:  Leukemia       Date:  2008-08-28       Impact factor: 11.528

6.  Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.

Authors:  Giulia Fabbri; Silvia Rasi; Davide Rossi; Vladimir Trifonov; Hossein Khiabanian; Jing Ma; Adina Grunn; Marco Fangazio; Daniela Capello; Sara Monti; Stefania Cresta; Ernesto Gargiulo; Francesco Forconi; Anna Guarini; Luca Arcaini; Marco Paulli; Luca Laurenti; Luigi M Larocca; Roberto Marasca; Valter Gattei; David Oscier; Francesco Bertoni; Charles G Mullighan; Robin Foá; Laura Pasqualucci; Raul Rabadan; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  J Exp Med       Date:  2011-06-13       Impact factor: 14.307

  6 in total
  14 in total

1.  Activation of the NOTCH1 pathway in chronic lymphocytic leukemia.

Authors:  Valentina Gianfelici
Journal:  Haematologica       Date:  2012-03       Impact factor: 9.941

2.  SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.

Authors:  S Jeromin; S Weissmann; C Haferlach; F Dicker; K Bayer; V Grossmann; T Alpermann; A Roller; A Kohlmann; T Haferlach; W Kern; S Schnittger
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

3.  Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Silvia Rasi; Valeria Spina; Alessio Bruscaggin; Sara Monti; Carmela Ciardullo; Clara Deambrogi; Hossein Khiabanian; Roberto Serra; Francesco Bertoni; Francesco Forconi; Luca Laurenti; Roberto Marasca; Michele Dal-Bo; Francesca Maria Rossi; Pietro Bulian; Josep Nomdedeu; Giovanni Del Poeta; Valter Gattei; Laura Pasqualucci; Raul Rabadan; Robin Foà; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

4.  Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?

Authors:  Reem Alsolami; Samantha Jl Knight; Anna Schuh
Journal:  Per Med       Date:  2013-06-01       Impact factor: 2.512

5.  Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.

Authors:  Peter Ouillette; Kamlai Saiya-Cork; Erlene Seymour; Cheng Li; Kerby Shedden; Sami N Malek
Journal:  Clin Cancer Res       Date:  2013-04-25       Impact factor: 12.531

6.  Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia.

Authors:  Nisar A Amin; Sriram Balasubramanian; Kamlai Saiya-Cork; Kerby Shedden; Nan Hu; Sami N Malek
Journal:  Clin Cancer Res       Date:  2016-08-17       Impact factor: 12.531

Review 7.  The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.

Authors:  S N Malek
Journal:  Oncogene       Date:  2012-09-24       Impact factor: 9.867

Review 8.  Clinical implications of the molecular genetics of chronic lymphocytic leukemia.

Authors:  Robin Foà; Ilaria Del Giudice; Anna Guarini; Davide Rossi; Gianluca Gaidano
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

9.  Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Authors:  P Baliakas; A Hadzidimitriou; L-A Sutton; D Rossi; E Minga; N Villamor; M Larrayoz; J Kminkova; A Agathangelidis; Z Davis; E Tausch; E Stalika; B Kantorova; L Mansouri; L Scarfò; D Cortese; V Navrkalova; M J J Rose-Zerilli; K E Smedby; G Juliusson; A Anagnostopoulos; A M Makris; A Navarro; J Delgado; D Oscier; C Belessi; S Stilgenbauer; P Ghia; S Pospisilova; G Gaidano; E Campo; J C Strefford; K Stamatopoulos; R Rosenquist
Journal:  Leukemia       Date:  2014-06-19       Impact factor: 11.528

10.  NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients.

Authors:  Kerstin Willander; Ravi Kumar Dutta; Jonas Ungerbäck; Rebeqa Gunnarsson; Gunnar Juliusson; Mats Fredrikson; Mats Linderholm; Peter Söderkvist
Journal:  BMC Cancer       Date:  2013-06-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.